or Try an Advanced Search...

    Treatment Of Human Diseases Stocks List

    Symbol Grade Name % Change
    ITCI A Intra-Cellular Therapies Inc. 2.11
    BFRG F Bullfrog AI Holdings, Inc 0.44
    View As Page of Charts
    Related Industries: Biotechnology Health Information Services
    Related Stock Lists: Human Diseases Medicine Aging Associated Diseases Alzheimer's Disease Artificial Intelligence Autism Autism Spectrum Disorder Biopharmaceutical Bipolar Disorder Cardiovascular And Other Diseases Cognitive Disorders Cognitive Dysfunction Cognitive Impairment Dementia Depressive Disorder Disorders Drug Development Dysfunction Fatty Liver Disease Hepatitis

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Human Diseases stocks.

    Symbol Grade Name Weight
    PSIL B AdvisorShares Psychedelics ETF 3.89
    IBRN B iShares Neuroscience and Healthcare ETF 3.71
    XPH B SPDR S&P Pharmaceuticals ETF 3.49
    FBT A First Trust Amex Biotech Index Fund 3.41
    IHE D iShares U.S. Pharmaceutical ETF 2.93
    View all Treatment Of Human Diseases ETFs...
    Compare ETFs
    Compare IBRN to IHE Compare PSIL to FBT Compare XPH to IHE

        Treatment Of Human Diseases Stocks Recent News

        Date Stock Title
        Nov 2 ITCI Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
        Nov 1 ITCI Intra-Cellular Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Oct 31 ITCI Intra-Cellular Therapies Inc (ITCI) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...
        Oct 30 ITCI Intra-Cellular Therapies, Inc. (ITCI) Q3 2024 Earnings Call Transcript
        Oct 30 ITCI Intra-Cellular jumps on Q3 beat as Caplyta outlook brightens
        Oct 30 ITCI ITCI Q3 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales
        Oct 30 ITCI Intra-Cellular Therapies (ITCI) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 ITCI Intra-Cellular: Q3 Earnings Snapshot
        Oct 30 ITCI Intra-Cellular Therapies GAAP EPS of -$0.25 misses by $0.04, revenue of $175.4M beats by $3.05M
        Oct 30 ITCI Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
        Oct 29 ITCI Intra-Cellular Therapies Q3 2024 Earnings Preview
        Related Industries: Biotechnology Health Information Services
        Related Stock Lists: Human Diseases Medicine Aging Associated Diseases Alzheimer's Disease Artificial Intelligence Autism Autism Spectrum Disorder Biopharmaceutical Bipolar Disorder Cardiovascular And Other Diseases Cognitive Disorders Cognitive Dysfunction Cognitive Impairment Dementia Depressive Disorder Disorders Drug Development Dysfunction Fatty Liver Disease Hepatitis
        Treatment Of Human Diseases

        Treatment of human diseases is the process of diagnosing, treating, and managing a medical condition or illness. This includes the use of medications, therapies, lifestyle changes, and other interventions to help improve a person's health and quality of life. Treatment plans are tailored to the individual and may involve a combination of treatments.

        Browse All Tags